371 related articles for article (PubMed ID: 3134662)
21. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
Bouffioux C
Scand J Urol Nephrol Suppl; 1991; 138():167-77. PubMed ID: 1838428
[No Abstract] [Full Text] [Related]
22. Superficial bladder disease: case studies and therapeutic advances.
Soloway MS; Droller MJ; Flanigan RC; Nseyo UO
Urology; 1992 Dec; 40(6 Suppl):11-22. PubMed ID: 1466118
[No Abstract] [Full Text] [Related]
23. Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897).
Van der Meijden AP; Hall RR; Macaluso MP; Pawinsky A; Sylvester R; Van Glabbeke M
Eur Urol; 1996; 29(2):199-203. PubMed ID: 8647147
[TBL] [Abstract][Full Text] [Related]
24. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
25. BCG in carcinoma in situ and superficial bladder tumors.
Lamm DL
Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069
[No Abstract] [Full Text] [Related]
26. Management of superficial transitional cell carcinoma of the bladder.
Fleischmann J; Goldberg G
Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
[TBL] [Abstract][Full Text] [Related]
27. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
28. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
29. [Our experience in the treatment of superficial cancer of the bladder with BCG].
Martínez E; Díaz I; Salvador J; Viladoms JM; Zungri E; Solé-Balcells FJ
Arch Esp Urol; 1989 May; 42(4):325-7. PubMed ID: 2782959
[TBL] [Abstract][Full Text] [Related]
30. Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG.
Soloway MS
Prog Clin Biol Res; 1990; 350():71-9. PubMed ID: 2117289
[TBL] [Abstract][Full Text] [Related]
31. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of principles in intravesical chemo- and immunotherapy for superficial bladder cancer.
Jauhiainen K; Rintala E; Kaasinen E; Ruutu M; Alfthan O
Arch Esp Urol; 1990; 43 Suppl 2():159-64. PubMed ID: 2129004
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of intravesical therapy for superficial bladder cancer.
Lamm DL
Urol Clin North Am; 1992 Aug; 19(3):573-80. PubMed ID: 1636241
[TBL] [Abstract][Full Text] [Related]
34. [Intravesical BCG vaccine in bladder cancer].
Beisland HO; Sander S
Tidsskr Nor Laegeforen; 1989 Jun; 109(17-18):1891-2. PubMed ID: 2749672
[TBL] [Abstract][Full Text] [Related]
35. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
36. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
[TBL] [Abstract][Full Text] [Related]
37. A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study.
Mori K; Lamm DL; Crawford ED
Urol Int; 1986; 41(4):254-9. PubMed ID: 3538593
[TBL] [Abstract][Full Text] [Related]
38. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
Huben RP
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
[TBL] [Abstract][Full Text] [Related]
39. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]